CompanyPrivateSouth San Francisco, CA

Asher Biotherapeutics, Inc

SEC EDGAR ClinicalTrials.gov

8-KNov 3Latest SEC filing

Form DApr 16$55M sold

November 2026

Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%

Nov 2Quarterly updateAmgen Aprea Therapeutics